Literature DB >> 15569275

Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali.

Yongchuan Gu1, Guangji Wang, Guoyu Pan, J Paul Fawcett, Jiye A, Jianguo Sun.   

Abstract

Astragaloside IV is an important constituent of Radix Astragali, a herbal remedy widely used in traditional Chinese medicine. Radix Astragali is administered orally but little is known about the transport properties and bioavailability of astragaloside IV. In this paper we report studies of the absorption of astragaloside IV in the perfused rat intestinal model, transport and uptake in Caco-2 cell monolayers and in vivo bioavailability in rat after an oral dose. In the perfused rat intestinal model, absorption of astragaloside IV was low from an aqueous solution but was significantly higher from a solution of Radix Astragali. Absorption was not affected by bile duct ligation. Transport through Caco-2 cells gave a very low permeability value (mean P(app) of 6.7+/-1.0 x 10(-8) cm/sec.) and uptake was unaffected by P-glycoprotein inhibitors. The absolute bioavailability of astragaloside IV in rat was 2.2%. The correlation between low permeability in vitro and poor bioavailability in vivo indicates in vitro absorption studies are useful in the evaluation of traditional Chinese medicines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569275     DOI: 10.1111/j.1742-7843.2004.t01-1-pto950508.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  16 in total

1.  Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells.

Authors:  C R Huang; G J Wang; X L Wu; H Li; H T Xie; H Lv; J G Sun
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

2.  Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102).

Authors:  Lin-Sen Qing; Ting-Bo Chen; Wen-Xia Sun; Li Chen; Pei Luo; Zhi-Feng Zhang; Li-Sheng Ding
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.441

3.  Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA barcoding sequence analyses.

Authors:  Wei-Lie Xiao; Timothy J Motley; Uchenna J Unachukwu; Clara Bik San Lau; Bei Jiang; Feng Hong; Ping-Chung Leung; Qing-Feng Wang; Philip O Livingston; Barrie R Cassileth; Edward J Kennelly
Journal:  J Agric Food Chem       Date:  2011-02-15       Impact factor: 5.279

4.  Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics.

Authors:  Jing Zhao; Qing Zhao; Jing-Ze Lu; Dan Ye; Sheng Mu; Xiao-Di Yang; Wei-Dong Zhang; Bing-Liang Ma
Journal:  Int J Nanomedicine       Date:  2021-09-14

5.  Pharmacokinetics of astragaloside iv in beagle dogs.

Authors:  Qi Zhang; Ling-Ling Zhu; Guo-Guang Chen; Yu Du
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Apr-Jun       Impact factor: 2.441

6.  Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells.

Authors:  Naveena B Janakiram; Cooma Indranie; Swamy V Malisetty; Patlolla Jagan; Vernon E Steele; Chinthalapally V Rao
Journal:  Pharm Res       Date:  2008-04-12       Impact factor: 4.580

7.  Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.

Authors:  Wei-Jian Zhang; Balz Frei
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

8.  A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.

Authors:  Jiahui Yu; Wen Zhang; Yiqian Zhang; Yadong Wang; Boli Zhang; Guanwei Fan; Yan Zhu
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

9.  Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation.

Authors:  Lin-Sen Qing; Shu-Lin Peng; Jian Liang; Li-Sheng Ding
Journal:  Molecules       Date:  2017-07-31       Impact factor: 4.411

10.  System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus.

Authors:  Shi-Jun Yue; Juan Liu; Wu-Wen Feng; Fei-Long Zhang; Jian-Xin Chen; Lan-Ting Xin; Cheng Peng; Hua-Shi Guan; Chang-Yun Wang; Dan Yan
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.